E5Integrating programmed cell death ligand 1 (PD-L1) and neutrophil to lymphocyte ratio (NLR) as predictive panel of response to nivolumab in non-small cell lung cancer (NSCLC)
Bennati, C, Mazza, V, D'Arcangelo, M, Minuti, G, Vecchiarelli, S, Attilia, L, Gili, A, Montanari, M, Landi, L, Cappuzzo, FVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx426.004
Date:
October, 2017
File:
PDF, 54 KB
english, 2017
File converter
More search results
More benefits 
